LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 194 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $466 | -15.1% | 7,776 | +2.2% | 0.00% | 0.0% |
| Q2 2023 | $549 | -5.5% | 7,610 | -3.7% | 0.00% | 0.0% |
| Q1 2023 | $581 | -19.4% | 7,900 | -26.9% | 0.00% | 0.0% |
| Q4 2022 | $721 | -99.9% | 10,800 | -1.3% | 0.00% | 0.0% |
| Q3 2022 | $942,000 | -3.2% | 10,937 | +0.3% | 0.00% | 0.0% |
| Q2 2022 | $973,000 | -20.9% | 10,908 | -0.2% | 0.00% | 0.0% |
| Q1 2022 | $1,230,000 | -28.5% | 10,935 | -1.9% | 0.00% | -50.0% |
| Q4 2021 | $1,721,000 | +5.0% | 11,145 | -5.2% | 0.00% | 0.0% |
| Q3 2021 | $1,639,000 | -9.5% | 11,762 | -14.8% | 0.00% | 0.0% |
| Q2 2021 | $1,811,000 | -13.2% | 13,808 | +0.9% | 0.00% | 0.0% |
| Q1 2021 | $2,086,000 | +57.7% | 13,685 | +2.9% | 0.00% | +100.0% |
| Q4 2020 | $1,323,000 | -19.4% | 13,300 | -22.7% | 0.00% | -50.0% |
| Q3 2020 | $1,641,000 | -37.6% | 17,211 | -26.7% | 0.00% | -33.3% |
| Q2 2020 | $2,628,000 | +119.0% | 23,494 | +42.4% | 0.00% | +50.0% |
| Q1 2020 | $1,200,000 | -25.3% | 16,500 | +7.1% | 0.00% | 0.0% |
| Q4 2019 | $1,606,000 | -16.8% | 15,400 | -20.6% | 0.00% | 0.0% |
| Q3 2019 | $1,931,000 | -60.5% | 19,400 | -54.7% | 0.00% | -66.7% |
| Q2 2019 | $4,886,000 | -18.3% | 42,805 | -10.0% | 0.01% | -25.0% |
| Q1 2019 | $5,978,000 | -1.1% | 47,553 | +6.8% | 0.01% | -11.1% |
| Q4 2018 | $6,044,000 | -50.6% | 44,543 | -0.1% | 0.01% | -35.7% |
| Q3 2018 | $12,241,000 | +17.3% | 44,597 | -11.5% | 0.01% | +7.7% |
| Q2 2018 | $10,436,000 | +12.4% | 50,373 | -10.4% | 0.01% | +8.3% |
| Q1 2018 | $9,285,000 | +57.7% | 56,216 | +30.7% | 0.01% | +71.4% |
| Q4 2017 | $5,888,000 | +5.6% | 42,997 | +5.0% | 0.01% | 0.0% |
| Q3 2017 | $5,577,000 | -19.4% | 40,959 | -28.2% | 0.01% | -22.2% |
| Q2 2017 | $6,922,000 | +27.3% | 57,020 | +11.0% | 0.01% | +28.6% |
| Q1 2017 | $5,438,000 | +8.9% | 51,379 | +4.5% | 0.01% | 0.0% |
| Q4 2016 | $4,994,000 | -3.9% | 49,146 | -3.5% | 0.01% | 0.0% |
| Q3 2016 | $5,196,000 | -36.2% | 50,911 | -25.4% | 0.01% | -41.7% |
| Q2 2016 | $8,144,000 | -1.4% | 68,284 | -11.4% | 0.01% | -7.7% |
| Q1 2016 | $8,257,000 | +77.7% | 77,105 | +79.9% | 0.01% | +85.7% |
| Q4 2015 | $4,647,000 | +52.9% | 42,858 | +20.8% | 0.01% | +40.0% |
| Q3 2015 | $3,040,000 | -43.6% | 35,488 | -33.6% | 0.01% | -37.5% |
| Q2 2015 | $5,392,000 | +14.3% | 53,438 | -12.6% | 0.01% | +14.3% |
| Q1 2015 | $4,717,000 | +114.8% | 61,173 | +48.3% | 0.01% | +133.3% |
| Q4 2014 | $2,196,000 | +10.6% | 41,262 | -2.4% | 0.00% | 0.0% |
| Q3 2014 | $1,986,000 | -48.4% | 42,262 | -31.6% | 0.00% | -50.0% |
| Q2 2014 | $3,847,000 | +23.9% | 61,767 | +33.8% | 0.01% | +20.0% |
| Q1 2014 | $3,105,000 | +114.6% | 46,162 | +67.9% | 0.01% | +150.0% |
| Q4 2013 | $1,447,000 | – | 27,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $8,459 | 3.32% |
| VILLERE ST DENIS J & CO LLC | 480,807 | $35,368,162 | 2.57% |
| Chicago Capital, LLC | 449,508 | $33,065,822 | 1.64% |
| RICE HALL JAMES & ASSOCIATES, LLC | 288,345 | $21,210,681 | 1.20% |
| Smith, Graham & Co., Investment Advisors, LP | 65,163 | $4,793,390 | 0.58% |
| Stephens Investment Management Group LLC | 455,089 | $33,476,347 | 0.56% |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 201,993 | $14,858,605 | 0.53% |
| WOODSTOCK CORP | 52,604 | $3,869,550 | 0.49% |
| Court Place Advisors, LLC | 15,533 | $1,142,607 | 0.41% |
| Jackson Creek Investment Advisors LLC | 12,726 | $936 | 0.39% |